Fusobacterium nucleatum

Hemolytic and Hemin-Dependent Peroxidase#

F. nucleatum possesses robust hemolytic activity and expresses hemin-dependent peroxidases that require iron prosthetic groups. Specializes in heme acquisition from lysed red blood cells and hemoglobin, particularly abundant in inflamed tissue where barrier breakdown releases luminal blood.

Iron (iron (Fe)²⁺/iron³⁺) is essential for cytochrome c oxidase, catalases, and peroxidases—core components of the anaerobic electron transport chain. Maintains multiple iron-uptake systems including transferrin-binding capacity and siderophore-mediated iron scavenging.

Manganese Requirement#

Manganese (manganese (Mn)²⁺) is critical for F. nucleatum superoxide dismutase (manganese-SOD), protecting against Oxidative Stress in the inflammatory colonic microenvironment. Elevated colonic manganese levels (part of the CRC metallomic signature) favor Fusobacterium proliferation.

The FadA Effector#

The FadA adhesin is a fibrils-associated adhesin that mediates bacterial adherence to intestinal epithelial cells and invasive interactions. FadA binds to E-cadherin on epithelial cells, activating beta-catenin/Wnt signaling and promoting epithelial proliferation. This signaling is pro-tumorigenic: constant FadA-E-cadherin engagement drives persistent Wnt activation, dysregulating cell growth and differentiation.

FadA also recruits and activates immune cells, sustaining chronic Metal-Driven Inflammation.

Biofilm Formation and Ecological Dominance#

F. nucleatum is a prolific biofilm former, particularly in CRC and IBD lesions. Biofilm architecture provides. Protected microenvironments where FadA-producing cells can persist despite host immunity.

Reduced oxygen availability (beneficial for obligate anaerobes).

Metabolic cross-feeding and division of labor (some cells specialize in iron scavenging, others in virulence). Reduced antibiotic and bile salt penetration. Biofilms composed of F. nucleatum and Porphyromonas gingivalis or Prevotella copri are particularly resistant to clearance.

Colorectal Cancer (CRC)#

Mechanistic link: Iron-rich inflamed tissue selects for Fusobacterium. High iron availability sustains FadA expression, driving E-cadherin cleavage and Wnt activation.^{[1]Colorectal cancer-associated microbiome patterns and signaturesLan Zhao, William C. Cho, Mark R. Nicolls · 2021Open reference 1 ↓}

F. nucleatum DNA is detectable in tumors, with CFU counts correlating with worse clinical outcomes.^{[2]Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community ProfilingThomas AM, Jesus EC, Lopes A et al. · 2016Open reference 2 ↓[3]A Systematic Review of Microbial Markers for Risk Prediction of Colorectal NeoplasiaYu L, Zhao G, Wang L et al. · 2022Open reference 3 ↓}

CRC microbiome signatures consistently show elevated Fusobacterium alongside iron and manganese elevation.^{[4]Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancerShaomin Zou, Chao Yang, Jieping Zhang et al. · 2024Open reference 4 ↓[5]Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancerYouwen Qin, Xin Tong, Wei-Jian Mei et al. · 2024Open reference 5 ↓}

FadA-mediated epithelial transformation is synergistic with dysplasia: the combination of disrupted tight junctions and oncogenic signaling accelerates malignant progression.^{[6]Identification of Microbial Markers across Populations in Early Detection of Colorectal CancerWu Y, Jiao N, Zhu R et al. · 2021Open reference 6 ↓[7]Metagenomic Analyses of the Gut Microbiota Associated with Colorectal AdenomaSaito K, Koido S, Odamaki T et al. · 2019Open reference 7 ↓}

FMT and dietary interventions that deplete Fusobacterium are under active investigation as adjuncts to CRC chemo- and immunotherapy.^{[8]Antitumor Effects of Fecal Microbiota Transplantation: Implications for Microbiome Modulation in Cancer TreatmentHui Xu, Chenxi Cao, Yuqing Ren et al. · 2022Open reference 8 ↓[9]Dissecting the Role of the Gut Microbiome and Fecal Microbiota Transplantation in Radio- and Immunotherapy Treatment of Colorectal CancerLena Van Dingenen, Charlotte Segers, Shari Wouters et al. · 2023Open reference 9 ↓}

Other Gastrointestinal and Gynecologic Cancers#

Pancreatic cancer: F. nucleatum is detected in pancreatic tumor microbiomes and contributes to a pro-tumorigenic Dysbiosis.^{[10]Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic TargetTao Zhang, Guangqi Gao, Hafiz Arbab Sakandar et al. · 2022Open reference 10 ↓}

Esophageal disease and upper-GI carcinogenesis: Fusobacterium is enriched in Type II (Gram-negative, inflammatory) esophageal microbiome signatures linked to reflux, Barrett's, and carcinogenesis.^{[11]Alageel 2025 — Examining the Microbiome Composition in Patients with Gastroesophageal Reflux Disease: A Systematic ReviewAlageel AA, Alomran DA, Alharbi HB et al. · 2025Open reference 11 ↓[12]Deshpande 2018 — Esophageal Microbiome Signatures and Host GeneticsDeshpande NP, Riordan SM, Castano-Rodriguez N et al. · 2018Open reference 12 ↓[13]Corruption of Bacterial-Host Homeostasis as a Potential Risk Factor and Biomarker for Upper Gastrointestinal CarcinogenesisCatala-Valentin AR, Mikhail S, Bernard JN et al. · 2021Open reference 13 ↓}

Periodontitis and Systemic Disease#

F. nucleatum is a core oral pathobiont in periodontitis and a bridging species in oral polymicrobial biofilms; its oral-to-gut and oral-to-vascular translocation links periodontal disease to systemic inflammation.^{[14]Periodontal Biomarkers in Cardiovascular Disease: Mechanisms, Diagnostics, and Clinical ImplicationsMax Foroughi, Keykavous Parang · 2026Open reference 14 ↓[15]Periodontitis and T2D — Endogenous and Microbial Biomarkers for Periodontitis and Type 2 Diabetes MellitusVarious · 2021Open reference 15 ↓[16]Tang 2022 — The Bidirectional Biological Interplay between Microbiome and Viruses in Periodontitis and Type-2 Diabetes MellitusBoyu Tang, Caixia Yan, Xin Shen et al. · 2022Open reference 16 ↓}

Oral Fusobacterium signatures are also altered in multiple sclerosis oral microbiome studies.^{[17]Bacterial Variation in the Oral Microbiota in Multiple Sclerosis PatientsZangeneh Z, Abdi-Ali A, Khamooshian K et al. · 2021Open reference 17 ↓[18]Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot studyLéo Boussamet, Emmanuel Montassier, Camille Mathé et al. · 2024Open reference 18 ↓}

Inflammatory Bowel Disease (IBD)#

Enriched in both Crohn's disease and ulcerative colitis, particularly in inflamed segments. Sustained by the iron-rich environment of bleeding intestinal mucosa. Perpetuates inflammation through FadA-driven immune activation and epithelial damage.

Metabolic Features#

Fermentative metabolism producing Butyrate and other short-chain fatty acids, but does not produce levels sufficient to be anti-inflammatory. Produces collagenase and other tissue-degrading proteases, compounding barrier disruption in IBD. Lacks robust SCFA-mediated immune tolerance mechanisms seen in Faecalibacterium prausnitzii or Roseburia.

Ecological Context#

Thrives in oxygen-limited environments with elevated iron (inflamed, hemorrhagic tissue). Outcompetes obligate anaerobes that lack robust iron acquisition (e.g., Faecalibacterium prausnitzii, Roseburia). Often co-enriched with other iron-dependent pathobionts like Bacteroides vulgatus and gram-positive iron-scavenging taxa.

Depleted in healthy gut; restored rapidly when inflammation and barrier breakdown create favorable conditions.

Clinical Significance#

Considered a CRC-predictive biomarker: presence of F. nucleatum in a healthy-appearing individual warrants further CRC screening. Abundance in biopsies correlates with tumor stage and patient prognosis independent of other variables. F. nucleatum presence may influence response to immunotherapy in CRC, as the organism's presence suppresses anti-tumor immunity.